These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35596584)

  • 1. Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.
    Lindgren U; Pullerits R; Lindberg C; Oldfors A
    Ann Neurol; 2022 Aug; 92(2):201-212. PubMed ID: 35596584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
    Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MT; Miller JA; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BR; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CG; Pruijn GJ; Chinoy H; van Engelen BG;
    Ann Rheum Dis; 2017 May; 76(5):862-868. PubMed ID: 28122761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion body myositis with early onset: a population-based study.
    Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
    J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
    Herbert MK; Stammen-Vogelzangs J; Verbeek MM; Rietveld A; Lundberg IE; Chinoy H; Lamb JA; Cooper RG; Roberts M; Badrising UA; De Bleecker JL; Machado PM; Hanna MG; Plestilova L; Vencovsky J; van Engelen BG; Pruijn GJ
    Ann Rheum Dis; 2016 Apr; 75(4):696-701. PubMed ID: 25714931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.
    Yamashita S; Tawara N; Sugie K; Suzuki N; Nishino I; Aoki M
    J Neurol Sci; 2024 Sep; 464():123164. PubMed ID: 39126732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and clinical utility of the anti-cytosolic 5'-nucleotidase 1A (cN1A) antibody test in sporadic inclusion body myositis: Report of 40 patients from a single neuromuscular center.
    Felice KJ; Whitaker CH; Wu Q; Larose DT; Shen G; Metzger AL; Barton RW
    Neuromuscul Disord; 2018 Aug; 28(8):660-664. PubMed ID: 30001928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
    Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
    Front Immunol; 2019; 10():745. PubMed ID: 31024569
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic Accuracy of Anti-CN1A on the Diagnosis of Inclusion Body Myositis. A Hierarchical Bivariate and Bayesian Meta-analysis.
    Mavroudis I; Knights M; Petridis F; Chatzikonstantinou S; Karantali E; Kazis D
    J Clin Neuromuscul Dis; 2021 Sep; 23(1):31-38. PubMed ID: 34431799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sporadic Inclusion Body Myositis and Autoantibodies].
    Yamashita S; Ando Y
    Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
    Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
    Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
    Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
    Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
    Alamr M; Pinto MV; Naddaf E
    Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion Body Myositis.
    Goyal NA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
    Chung SH; Bent EI; Weiss MD; Gardner GC
    Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of inclusion body myositis.
    Greenberg SA
    Curr Opin Rheumatol; 2013 Nov; 25(6):753-62. PubMed ID: 24067380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.
    Paul P; Liewluck T; Ernste FC; Mandrekar J; Milone M
    Muscle Nerve; 2021 Apr; 63(4):490-496. PubMed ID: 33373040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.
    Shelly S; Mielke MM; Mandrekar J; Milone M; Ernste FC; Naddaf E; Liewluck T
    Neurology; 2021 May; 96(21):e2653-e2661. PubMed ID: 33879596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
    Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
    Salam S; Dimachkie MM; Hanna MG; Machado PM
    Clin Exp Rheumatol; 2022 Feb; 40(2):384-393. PubMed ID: 35225226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.